{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:06:26Z","timestamp":1765728386619},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T00:00:00Z","timestamp":1275955200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00198-010-1309-z","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T16:01:17Z","timestamp":1275926477000},"page":"943-954","source":"Crossref","is-referenced-by-count":31,"title":["Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors"],"prefix":"10.1007","volume":"22","author":[{"given":"S. M.","family":"Cadarette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Brookhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,8]]},"reference":[{"key":"1309_CR1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025. J Bone Miner Res 22:465\u2013475","journal-title":"J Bone Miner Res"},{"key":"1309_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, Newberry S, Maglione M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197\u2013213","journal-title":"Ann Intern Med"},{"key":"1309_CR3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.4065\/82.12.1493","volume":"82","author":"P Kothawala","year":"2007","unstructured":"Kothawala P, Badamgarav E, Ryu S et al (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82:1493\u20131501","journal-title":"Mayo Clin Proc"},{"key":"1309_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.12.002","volume":"122","author":"ES Siris","year":"2009","unstructured":"Siris ES, Selby PL, Saag KG et al (2009) Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 122:S3\u2013S13","journal-title":"Am J Med"},{"key":"1309_CR5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00198-009-0991-1","volume":"21","author":"MM Wilkes","year":"2010","unstructured":"Wilkes MM, Navickis RJ, Chan WW et al (2010) Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant\/persistent postmenopausal women in clinical practice versus randomized controlled trials. Osteoporos Int 21:679\u2013688","journal-title":"Osteoporos Int"},{"key":"1309_CR6","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1517\/14656560903140533","volume":"10","author":"V Rabenda","year":"2009","unstructured":"Rabenda V, Hiligsmann M, Reginster JY (2009) Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence. Expert Opin Pharmacother 10:2303\u20132315","journal-title":"Expert Opin Pharmacother"},{"key":"1309_CR7","unstructured":"Imaz I, Zegarra P, Gonzalez-Enriquez J et al. (2010) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int. doi: 10.1007\/s00198-00009-01134-00194"},{"key":"1309_CR8","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","volume":"366","author":"BB Granger","year":"2005","unstructured":"Granger BB, Swedberg K, Ekman I et al (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366:2005\u20132011","journal-title":"Lancet"},{"key":"1309_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR et al (2006) A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333:15","journal-title":"BMJ"},{"issue":"Suppl 10","key":"1309_CR10","first-page":"613","volume":"60","author":"J Curtis","year":"2009","unstructured":"Curtis J, Larson J, Delzell E et al (2009) Does the benefit of medication adherence relate more to a drug effect or the behavior itself? Quantifying the effect of adherence behavior using data from the placebo arms of the WHI. Arthritis Rheum 60(Suppl 10):613 (abstract)","journal-title":"Arthritis Rheum"},{"key":"1309_CR11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-148-12-200806170-00222","volume":"148","author":"American College of Physicians","year":"2008","unstructured":"American College of Physicians (2008) Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 148:956\u2013961","journal-title":"Ann Intern Med"},{"key":"1309_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","volume":"297","author":"JN Rasmussen","year":"2007","unstructured":"Rasmussen JN, Chong A, Alter DA (2007) Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Jama 297:177\u2013186","journal-title":"Jama"},{"key":"1309_CR13","first-page":"45","volume-title":"Health behavior and health education: theory, research, and practice","author":"NK Janz","year":"2002","unstructured":"Janz NK, Champion VL, Strecher VJ (2002) The health belief model. In: Glanz K, Rimer BK, Lewis FM (eds) Health behavior and health education: theory, research, and practice. Jossey-Bass, San Francisco, pp 45\u201366"},{"key":"1309_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MLR.0b013e318032937e","volume":"45","author":"MR DiMatteo","year":"2007","unstructured":"DiMatteo MR, Haskard KB, Williams SL (2007) Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care 45:521\u2013528","journal-title":"Med Care"},{"key":"1309_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487\u2013497","journal-title":"N Engl J Med"},{"key":"1309_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A et al (2008) Medication compliance and persistence: terminology and definitions. Value Health 11:44\u201347","journal-title":"Value Health"},{"key":"1309_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","volume":"10","author":"AM Peterson","year":"2007","unstructured":"Peterson AM, Nau DP, Cramer JA et al (2007) A checklist for medication compliance and persistence studies using retrospective databases. Value Health 10:3\u201312","journal-title":"Value Health"},{"key":"1309_CR18","doi-asserted-by":"crossref","unstructured":"Cadarette SM, Burden AM (2010) Measuring and improving adherence to osteoporosis pharmacotherapy. Curr Opin Rheumatol. doi: 10.1097\/BOR.0b013e32833ac7fe","DOI":"10.1097\/BOR.0b013e32833ac7fe"},{"key":"1309_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","volume":"9","author":"HA Pols","year":"1999","unstructured":"Pols HA, Felsenberg D, Hanley DA et al (1999) Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT Study. Fosamax International Trial Study Group. Osteoporos Int 9:461\u2013468","journal-title":"Osteoporos Int"},{"key":"1309_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","volume":"2008","author":"S Suissa","year":"2008","unstructured":"Suissa S (2008) Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol 2008:329\u2013335","journal-title":"Am J Epidemiol"},{"key":"1309_CR21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0895-4356(92)90047-Q","volume":"45","author":"WA Ray","year":"1992","unstructured":"Ray WA, Griffin MR, Fought RL et al (1992) Identification of fractures from computerized Medicare files. J Clin Epidemiol 45:703\u2013714","journal-title":"J Clin Epidemiol"},{"key":"1309_CR22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/0003-4819-148-9-200805060-00003","volume":"148","author":"SM Cadarette","year":"2008","unstructured":"Cadarette SM, Katz JN, Brookhart MA et al (2008) Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med 148:637\u2013646","journal-title":"Ann Intern Med"},{"key":"1309_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6874-8-24","volume":"8","author":"SA Foster","year":"2008","unstructured":"Foster SA, Foley KA, Meadows ES et al (2008) Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates. BMC Womens Health 8:24","journal-title":"BMC Womens Health"},{"key":"1309_CR24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00198-004-1818-8","volume":"16","author":"CS Pickney","year":"2005","unstructured":"Pickney CS, Arnason JA (2005) Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int 16:1156\u20131160","journal-title":"Osteoporos Int"},{"key":"1309_CR25","first-page":"251","volume":"120","author":"MA Brookhart","year":"2007","unstructured":"Brookhart MA, Patrick AR, Avorn J et al (2007) Adherence to lipid-lowering therapy and the use of preventive health care services: an investigation of the healthy user effect. Am J Epidemiol 120:251\u2013256","journal-title":"Am J Epidemiol"},{"key":"1309_CR26","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","volume":"119","author":"CR Dormuth","year":"2009","unstructured":"Dormuth CR, Patrick AR, Shrank WH et al (2009) Statin adherence and risk of accidents: a cautionary tale. Circulation 119:2051\u20132057","journal-title":"Circulation"},{"key":"1309_CR27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pec.2008.08.001","volume":"74","author":"L Giangregorio","year":"2009","unstructured":"Giangregorio L, Dolovich L, Cranney A et al (2009) Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns 74:213\u2013220","journal-title":"Patient Educ Couns"},{"key":"1309_CR28","unstructured":"Sale JEM, Beaton DE, Sujic R et al. (2010) \u201cIf it was osteoporosis, I would have really hurt myself.\u201d Ambiguity about osteoporosis and osteoporosis care despite a screening program to educate fragility fracture patients. J Eval Clin Pract 16:590\u2013596"},{"key":"1309_CR29","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","volume":"90","author":"MF Holick","year":"2005","unstructured":"Holick MF, Siris ES, Binkley N et al (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215\u20133224","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR30","doi-asserted-by":"crossref","unstructured":"Miller PD, Derman RJ (2010) What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteoporos Int. doi: 10.1007\/s00198-010-1208-3","DOI":"10.1007\/s00198-010-1208-3"},{"key":"1309_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjmed.2006.03.029","volume":"120","author":"MA Brookhart","year":"2007","unstructured":"Brookhart MA, Avorn J, Katz JN et al (2007) Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med 120:251\u2013256","journal-title":"Am J Med"},{"key":"1309_CR32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.1687","volume":"18","author":"EE Roughead","year":"2009","unstructured":"Roughead EE, Ramsay E, Priess K et al (2009) Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates. Pharmacoepidemiol Drug Saf 18:69\u201375","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1309-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1309-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1309-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T22:09:27Z","timestamp":1559167767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1309-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,8]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1309-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,8]]}}}